Investors with a lot of money to spend have taken a bearish stance on Moderna MRNA.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MRNA, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 12 uncommon options trades for Moderna.
This isn't normal.
The overall sentiment of these big-money traders is split between 25% bullish and 41%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $381,093, and 5 are calls, for a total amount of $293,373.
Predicted Price Range
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $22.5 and $65.0 for Moderna, spanning the last three months.
Volume & Open Interest Trends
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1677.71 with a total volume of 5,741.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $22.5 to $65.0 over the last 30 days.
Moderna Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | CALL | TRADE | BULLISH | 01/16/26 | $22.8 | $22.25 | $22.6 | $22.50 | $113.0K | 2 | 50 |
| MRNA | PUT | SWEEP | BEARISH | 01/17/25 | $2.96 | $2.91 | $2.96 | $35.00 | $73.1K | 2.1K | 363 |
| MRNA | PUT | SWEEP | NEUTRAL | 11/15/24 | $0.84 | $0.7 | $0.84 | $41.00 | $65.5K | 4.2K | 2.0K |
| MRNA | PUT | SWEEP | BEARISH | 04/17/25 | $7.95 | $7.8 | $7.9 | $40.00 | $61.6K | 180 | 132 |
| MRNA | PUT | SWEEP | NEUTRAL | 11/15/24 | $1.19 | $1.09 | $1.18 | $41.00 | $61.3K | 4.2K | 1.1K |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
After a thorough review of the options trading surrounding Moderna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Where Is Moderna Standing Right Now?
- With a trading volume of 5,268,882, the price of MRNA is down by -1.86%, reaching $41.35.
- Current RSI values indicate that the stock is may be oversold.
- Next earnings report is scheduled for 98 days from now.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
